Author

M. Emmenegger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Assay:proteomics· 4 Approach:experimental assay· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Aguzzi· 3 shared A. Ilsley· 2 shared A. S. Morgunov· 2 shared S. Fiedler· 2 shared S. R. A. Devenish· 2 shared T. P. J. Knowles· 2 shared V. Kosmoliaptsis· 2 shared A. A. A. Aguzzi· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Aguzzi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration

S. Fiedler, S. R. A. Devenish, A. S. Morgunov, A. Ilsley, F. Ricci, M. Emmenegger, V. Kosmoliaptsis, E. S. Theel, J. R. Mills, A. M. Sholukh, A. A. A. Aguzzi, A. Iwasaki, A. K. Lynn, T. P. J. Knowles

The paper links antiviral activity of therapeutic antibodies to their affinity and concentration by comparing them to serological fingerprints in convalescent sera.

bioRxiv · Feb 3, 2022Biochemistry

Understanding the role of memory re-activation and cross-reactivity in the defense against SARS-CoV-2

V. Denninger, C. K. Xu, G. Meisl, A. S. Morgunov, S. Fiedler, A. Ilsley, M. Emmenegger, A. Y. Malik, M. A. Piziorska, M. M. Schneider, S. R. A. Devenish, V. Kosmoliaptsis, A. Aguzzi, H. Fiegler, T. P. J. Knowles

This study uses microfluidic antibody-affinity profiling to assess cross-reactive antibodies against SARS-CoV-2 in convalescent patients and pre-pandemic sera, finding low affinity and concentration against SARS-CoV-2 spike protein.

bioRxiv · Jul 23, 2021 · PreprintBiophysics

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

M. Emmenegger, S. S. Kumar, V. Emmenegger, T. Malinauskas, T. Buettner, L. Rose, P. Schierack, M. F. Sprinzl, C. J. Sommer, K. J. Lackner, A. Aguzzi, D. Roggenbuck, K. B. M. Frauenknecht

This study finds that anti-prothrombin autoantibodies are enriched after SARS-CoV-2 infection and linked to antibody response strength and disease severity.

bioRxiv · Jun 21, 2021Immunology

Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19

C. Cervia, J. Nilsson, Y. Zurbuchen, A. Valaperti, J. Schreiner, A. Wolfensberger, M. E. Raeber, S. Adamo, M. Emmenegger, S. Hasler, P. P. Bosshard, E. De Cecco, E. Baechli, A. Rudiger, M. Stuessi-Helbling, , O. Boyman

This study compares SARS-CoV-2-specific antibody responses in mild and severe COVID-19 patients and healthcare workers, finding higher systemic IgA and IgG in severe cases and mucosal IgA in asymptomatic exposed individuals.

bioRxiv · May 21, 2020Immunology